Essa Pharma Stock Technical Analysis
| EPIX Stock | USD 6.40 0.08 1.27% |
As of the 23rd of April, ESSA Pharma shows the Standard Deviation of 5.05, market risk adjusted performance of (0.46), and Mean Deviation of 3.46. ESSA Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for ESSA Pharma, which can be compared to its peers. Please confirm ESSA Pharma market risk adjusted performance and treynor ratio to decide if ESSA Pharma is priced fairly, providing market reflects its regular price of 6.4 per share. Given that ESSA Pharma has information ratio of (0.08), we urge you to verify ESSA Pharma's prevailing market performance to make sure the company can sustain itself at some point in the future.
ESSA Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ESSA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ESSAESSA |
ESSA Pharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 19.4 | Strong Buy | 4 | Odds |
Most ESSA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ESSA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ESSA Pharma, talking to its executives and customers, or listening to ESSA conference calls.
ESSA Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ESSA Pharma Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ESSA Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
ESSA Pharma Trend Analysis
Use this graph to draw trend lines for ESSA Pharma. You can use it to identify possible trend reversals for ESSA Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ESSA Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.ESSA Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ESSA Pharma applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that ESSA Pharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 50.54, which is the sum of squared deviations for the predicted ESSA Pharma price change compared to its average price change.About ESSA Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ESSA Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ESSA Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ESSA Pharma price pattern first instead of the macroeconomic environment surrounding ESSA Pharma. By analyzing ESSA Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ESSA Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ESSA Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Net Current Asset Value | 3.6M | 3.2M | Days Payables Outstanding | 5.6K | 3.5K |
ESSA Pharma April 23, 2024 Technical Indicators
Most technical analysis of ESSA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ESSA from various momentum indicators to cycle indicators. When you analyze ESSA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.46) | |||
| Mean Deviation | 3.46 | |||
| Coefficient Of Variation | (1,629) | |||
| Standard Deviation | 5.05 | |||
| Variance | 25.55 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | (0.47) | |||
| Maximum Drawdown | 25.93 | |||
| Value At Risk | (7.20) | |||
| Potential Upside | 7.71 | |||
| Skewness | (0.86) | |||
| Kurtosis | 5.51 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for ESSA Stock analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Return On Assets (0.13) | Return On Equity (0.17) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.